SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
Menu
Our Story
Leadership
History
Awards
Locations
Locations
North America
USA
Danner Laboratory
R&D | Clinical services
Canada
Pacgen Life Science
Clinical services
ASIA
Taiwan
GBC Headquarters
R&D | Manufacturing | Sales marketing
China
DGBC
DGBC
Sales marketing
COME CONNECT WITH US
Come connect with us and learn how our experts can help with your next complex project
Find Out More
Leadership
Mr. TC Lin
Chairman & CEO
General Biologicals Corp. Chairman & CEO
Danner Lab Inc Chairman & CEO
Pacgen Life Science Chairman & CEO
CurieMed Corporation Chairman & CEO
GB GENES CORP. Board director
Taiwan Genomic Industry Alliance Inc. Board Director
Ace Medical Technology Co., Ltd Board Director
Mr. Frank Lin
President
Director of General Biologicals Corp.
GB GENES CORP. Chairman
Director of GB GENES CORP.
Representative of Juristic Person of GB GENES CORP.
Representative of Juristic Person of Viarich Biotechnology Co., Ltd
Ms. Cherie Lin
VP Healthcare
B.A.in New York University, Master of Business.
10+ Extensive experiences and roles in sales marketing.
Supervising clinical laboratory and a clinic.
Dr. Yin-Peng Chen
VP Technology
Ph.D, Molecular and Cellular Biology and Pathology Program
2009-Focus Diagnostics, Senior Staff Scientist, Healthcare Diagnostics Group.
2012-GenMark Diagnostics, Staff Scientist.
2015-Invivoscribe Technologies, Senior Staff Scientist.
Mr. Leo Liu
VP
1998-Head of Laboratory Department, Chenxin Hospital
2002-Head of Department of Nuclear Medicine Immunology Laboratory,
　　　Hsinchu Hospital
2005-Director of Quality Control Department of CurieMed Corp
2010-Director of CurieMed Corp Medical Laboratory
2013-Director of Quality Control Department of General Biologicals Corp.
2014-General Biologicals Corp. Senior Project Manager
2019-General Biologicals Corp. Director
Mr. Wally Fan
Director Asia Pacific Sales
The Open University of Hong Kong Postgraduate Certificate in Business Administration
1996-Thermo Fisher Scientific commercial leader Northeast Asia
2012-DYNEX TECHNOLOGIES, Inc. Asia Pacific Sales Director
Mr. George Guo
Sr. Consultant
1999- PwC Taiwan, Audit Leader Team (Hsinchu Branch)
2001 - Assistant Finance Manager of Accton (Shenzhen) Co., Ltd.
2002-Shanghai Guangzhi Technology Development Co., Ltd. Financial Manager
2004-T3EX Global Holdings Co., Ltd. Audit Manager
2005-COWealth (China) Medical Technology Trading Co., Ltd. Financial Manager
2008- COWealth Medical Holdings Co., Ltd. Financial/Operation Director
2012-Shanghai Runda Medical Technology Co., Ltd. Deputy Director of Operations
2015-Roche Diagnostics (Shanghai) Co., Ltd. Senior Business Development Director
View all
Put away
Board Members
T.C. Lin
General Biologicals Corp. Chairman & CEO
Danner Lab Inc Chairman & CEO
Pacgen Life Science Chairman & CEO
CurieMed Corporation Chairman & CEO
GB GENES CORP. Board director
Taiwan Genomic Industry Alliance Inc. Board Director
Ace Medical Technology Co., Ltd Board Director
Pi-Hua Chen
CHLITINA Holding Limited. Chairman

Representative of Juristic Person of General Biologicals Corp.
Frank Lin
General Biologicals Corp. General Manager
Director of General Biologicals Corp.
GB GENES CORP. Chairman
Director of GB GENES CORP.
Representative of Juristic Person of GB GENES CORP.
Representative of Juristic Person of Viarich Biotechnology Co., Ltd
Board Members
Ted Chaung
Chief Technology Officer, SCH Biosciences Co. Ltd.
Independent Director, General Biologicals Corp.
Jen-Leigh Wu
Academia Sinica Visiting Chair Professor
NCKU Adjunct Professor
Moderator of the Ministry of Science and Technolohy
NTOU National Taiwan Ocean University Chair Professor
Independent Director, PRIT Biotech Co. Ltd.
Independent Director, General Biologicals Corp.
Cheryl Lin
President, Glonova Co.
Consultant, T-TOP Clinical Research Co.
Director, Yolk Partners Co.
Independent Director, General Biologicals Corp.
Steve, H. S. Kuo
The Ambassador-at-large of Taiwan
Acer Medical Inc./Independent Director and Compensation Committee
Independent Director, General Biologicals Corp.
Reveal. Better Life.
Brand Story
Over 40 Years' Experience, our purpose has remained the same — to create better and more affordable in-vitro diagnostics that are accessible to everyone. Our in-vitro diagnostic tests portfolio including respiratory infections, blood virology, women’s and sexual health, oncology and human genetics and emerging infectious diseases, and equipment are now the trusted solution for hospital professionals, lab technicians, blood banks, and consumers worldwide.
Vision
To be the global benchmark for the manufacture and provision of diagnostics and healthcare technologies.
Mission
To create and implement the use of state-of-the-art diagnostic technologies that enhance the lives of people worldwide.
Values We Deliver
Integrity
With ethical conduct central to our operations, we value honesty and openness above all else, welcoming any contributions that help us maintain our exceptional standards.
Insight
We continually strive to achieve our customers’ goals in the most dynamic and effective ways possible.
Integration
With all voices relevant, we incorporate all opinions and resources available to deliver the optimal experience for our customers.
Innovation
At GBC, we never rest on our successes and are committed to innovation and improvement at all times in all areas.
Security
As well as safeguarding the health of the wider population through diagnostic technology, we secure the well-being of all our staff by applying strict and conscientious research and manufacturing practices.
Solution
Beyond manufacturing, GBC serves as a knowledge resource that can be drawn on to address the needs of any given sector.
Adaptability
With the constantly changing environmental and social landscape, GBC remains committed to meeting peoples’ needs no matter what the circumstances.
Swipe left to view all
Business Areas
LABORATORY DIAGNOSTICS
PHARMA
SOLUTIONS
CONSUMERS
Start Making a Difference.
Join GBC
Awards
All
{{c["c_name_"+lang]}}
Classification
All
All
{{c["c_name_"+lang]}}
{{a["a_title_"+lang]}}
Awarded by
{{a["a_aby_"+lang]}}
Year
{{a.a_year}}
Title Awarded by Year
{{a["a_title_"+lang]}}
{{a["a_aby_"+lang]}} {{a.a_year}}
{{p+1}}
History
1984
The year it all got started.
Founded and funded by Taiwan Government, GBC was created as part of Taiwan’s national ‘Hepatitis Prevention and Vaccine Program’. Dr. Zong Mei Lin, the founder of GBC, used ‘Direct Sandwich’ antibody technology in the manufacture of HBV diagnostic kits.
1987
The first products are launched.
Our RIA (Radioimmunoassay) products are released, making us the only RIA company in Taiwan, with Hepatitis tests being the first product line to be launched.
1993
We introduce the first immunoassay (ELISA) products.
GBC is proud to announce new hepatitis products: HBsAg and anti-HCV. These two products have gone on to remain the top sellers within the industry even after 30 years.
1996
GBC enters the laboratory services market.
GBC acquires its first company proving solutions for hospitals, CurieMed, to enter the service industry. CurieMed provides quality tests samples collected from hospitals, clinics, and other labs as well as BOT solutions.
1998
Taiwan GMP Certified.
1999
Diversification
GBC expands its business portfolio by investing in StemCyte Inc., a global leader in cord blood therapeutics that offers public and private cord blood banking.
2002
GBC is listed on the Taiwan Emerging Stock Board (4117).
2004
ISO-13485 Certified.
2008
Real-Time PCR first product launch.
Knowing someone has hepatitis B is not enough — doctors need to know the viral load in order to correctly treat and monitor the condition. To this end, we launch our first GB HBV RealQuant PCR Kit.
2012
Innovation continues.
With Liver Fibrosis a critical part of liver disease that clinical doctors needed to identify, we started working with ITRI (Industrial Technology Research Institute of Taiwan). As a result, BioFibroScore® is born.
2010
Expansion in the south with the Kaohsiung Science Park.
2012
TTQS Certified.
GBC becomes certified by the Taiwan Train Quality System (TTQS).
2013
KFDA Certified.
2014
Our 30th Anniversary.
For more than 30 years, GBC has focused on creating high-performance diagnostic technologies that are available to all.
2014
New drug development
GBC develops its first drug, P113, a therapeutic peptide drug for the topical treatment of Oral Candidiasis. P113 finishes its promising Phase IIb FDA clinical trial, proving effective for gingivitis, candida albicans, vaginal Candidiasis, Cystic fibrosis, and anti-plague for dogs’ teeth.
2015
Acquisition to strengthen service business in USA
GBC acquires Danner Laboratory located in San Diego, CA USA. Danner Laboratory offers cytology and molecular tests in addition to all hepatitis, tumor markers, fertility, infectious disease, and thyroid tests manufactured by GBC.
2015
Heading toward personalized healthcare
With diagnostics and drugs are dependent upon each other more than ever, new non-invasive technologies are being developed that diagnosis diseases that couldn’t be detected before. GBC’s is developing these groundbreaking products through partnerships in Taiwan, China, the USA, and Canada.
2015
P113+
P113+ is certified by CTFA as an INCI (International Nomenclature Cosmetic Ingredient).
2016
GBC enters the personal care and cosmetics market
GBC establishes its own consumable brand name ‘oh care’ to launch oral care, feminine products, pets, and medical devices all using the P113 peptide ingredient.
2016
Expanded our sales marketing office in Dongguan, China
We expand our sales marketing office in Dongguan, China, concentrating on our IVD and personal care products.
2019
CellBio Technology is launched, a Liquid Biopsy application that helps cancer cell early detection, drug selection, and disease monitoring.
2021
Clinical Lab established
Our Clinical Lab is setup in Vancouver, BC, Canada, to provide clinical services such as COVID-19.
About GBC
Our Story Leadership HIstory Award & Recognition Locations
Solutions
COVID-19 Solution Digital Pathology CDMO BY GBC
Products
In Vitro Diagnostics (IVD) Solutions Blood Screening Biomaterial
Our Brands
GB Pharma CurieMed Danner Lab
R & D
Pharma Diagnostic Solution
Innovation
ESG
Investors
About Us Reporting Corporate Governance FAQ
My Account
Media
Press Release/Events Award & Recognition Marketing Downloads
Join Us
Contact Us
Documentation
Copyright © 2024 General Biologicals Corporation
Privacy Policy Terms of Use